Regional distribution of polymorphisms associated to the disease-causing gene of spinocerebellar ataxia type 3
Open Access
- 12 December 2024
- journal article
- research article
- Published by Springer Nature in Journal of Neurology
- Vol. 272 (1) , 1-12
Abstract
Introduction: Knowledge about the distribution and frequency of the respective haplotypes on the wildtype and mutant allele is highly relevant in the context of future gene therapy clinical studies in Spinocerebellar Ataxia Type 3, the most common autosomal dominantly inherited ataxia. Single nucleotide polymorphisms associated to the disease-causing gene, ATXN3 , have been determined. We wanted to investigate the frequency and regional distribution of two intragenic single nucleotide polymorphisms (SNPs) in a large European SCA3 cohort and their relation to the clinical phenotype. Methods: The genotypes of the two polymorphisms at base pair positions 987 and 1118 of the ATXN3 were determined for their co-localization on the normal and expanded allele, respectively, in 286 SCA3 mutation carriers and 117 healthy controls from 11 European sites. Results: The distribution of genotypes on the expanded allele differed from those of the wildtype allele of SCA3 mutation carriers and of healthy controls, and was mainly influenced by the regional origin. In our cohort, no particular clinical phenotype was associated with any specific haplotype. Conclusions: Our results confirm distinct allocations of SNPs associated to the expanded ATXN3 , and accordingly the consideration of allele-specific therapies.Keywords
Funding Information
- Bundesministerium für Forschung, Technologie und Raumfahrt
- Netherlands Organisation for Health Research and Development
- Fundação para a Ciência e a Tecnologia, Portugal
- Medical Research Council, United Kingdom
- Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE) in der Helmholtz-Gemeinschaft
This publication has 35 references indexed in Scilit:
- Antisense Oligonucleotide Silencing Reverses Abnormal Neurochemistry in Spinocerebellar Ataxia 3 MiceAnnals of Neurology, 2023
- Protocol for the Characterization of the Cytosine-Adenine-Guanine Tract and Flanking Polymorphisms in Machado-Joseph DiseaseThe Journal of Molecular Diagnostics, 2020
- Pathogenesis of SCA3 and implications for other polyglutamine diseasesNeurobiology of Disease, 2020
- Development of an AAV-Based MicroRNA Gene Therapy to Treat Machado-Joseph DiseaseMolecular Therapy - Methods & Clinical Development, 2019
- From Pathogenesis to Novel Therapeutics for Spinocerebellar Ataxia Type 3: Evading Potholes on the Way to TranslationNeurotherapeutics, 2019
- Oligonucleotide therapy mitigates disease in spinocerebellar ataxia type 3 miceAnnals of Neurology, 2018
- Inventory of Non-Ataxia Signs (INAS): Validation of a New Clinical Assessment InstrumentThe Cerebellum, 2012
- Mutational Origin of Machado-Joseph Disease in the Australian Aboriginal Communities of Groote Eylandt and YirrkalaArchives of Neurology, 2012
- Asian Origin for the Worldwide-Spread Mutational Event in Machado-Joseph DiseaseArchives of Neurology, 2007
- The genomic structure and expression of MJD, the Machado-Joseph disease geneJournal of Human Genetics, 2001